You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NKTR-358

Showing 1 - 25 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Lenexa (LY3471851, Placebo)

Completed
  • Healthy
  • Lenexa, Kansas
    PRA Health Sciences
Jul 6, 2021

Healthy Trial in Dallas (LY3471851, Placebo, Levocetirizine)

Recruiting
  • Healthy
  • Dallas, Texas
    Covance Dallas
Oct 18, 2022

Moderate to Severe Atopic Dermatitis Trial in United States (Rezpegaldesleukin, Placebo)

Recruiting
  • Moderate to Severe Atopic Dermatitis
  • Los Angeles, California
  • +4 more
Nov 13, 2023

Systemic Lupus Erythematosus Trial in United States (LY3471851, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Anniston, Alabama
  • +13 more
Jul 6, 2021

Dermatitis, Atopic Trial in United States (LY3471851, Placebo)

Completed
  • Dermatitis, Atopic
  • North Little Rock, Arkansas
  • +19 more
Jan 24, 2023

Colitis, Ulcerative Trial in Worldwide (LY3471851, Placebo)

Terminated
  • Colitis, Ulcerative
  • Litchfield Park, Arizona
  • +115 more
Aug 17, 2022

Healthy Trial in Cypress (LY3471851, Placebo)

Completed
  • Healthy
  • Cypress, California
    WCCT Global
Mar 16, 2020

Psoriasis Trial in United States (LY3471851, Placebo)

Completed
  • Psoriasis
  • North Little Rock, Arkansas
  • +23 more
Aug 10, 2021

Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))

Completed
Has Results
  • Locally Recurrent Breast Cancer
  • Metastatic Breast Cancer
  • NKTR-102
  • Treatment of Physician's Choice (TPC)
  • Flagstaff, Arizona
  • +152 more
May 6, 2021

Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

Not yet recruiting
  • Colorectal Cancer
  • +8 more
  • (no location specified)
Jan 5, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
Mar 18, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

AssesSment of Early deteCtion basEd oN liquiD Biopsy in

Recruiting
  • Intracranial Tumors
  • early detection test
  • Guangzhou, Guangdong, China
    Zhujiang Hospital
Dec 28, 2022

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

Lung Cancer Trial in Houston (NKTR-255, Durvalumab)

Not yet recruiting
  • Lung Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Omaha, Nebraska
  • +3 more
Dec 16, 2022

SARCOMA Trial in New York, Houston (NKTR-214, Nivolumab)

Active, not recruiting
  • SARCOMA
  • New York, New York
  • +1 more
May 6, 2022

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma Trial in United States (NKTR-255,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Mar 31, 2022

Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)

Completed
  • Urinary Bladder Neoplasm
  • Neoplasm Metastasis
  • Bempegaldesleukin
  • Nivolumab
  • San Francisco, California
  • +69 more
Jul 22, 2022

Malignant Solid Tumor Trial in Belgium, United States (NKTR-102 145 mg/m2, NKTR-102 120 mg/m2, NKTR-102 95 mg/m2)

Completed
Has Results
  • Malignant Solid Tumor
  • NKTR-102 145 mg/m2
  • +3 more
  • Los Angeles, California
  • +6 more
Jul 9, 2021

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Head Neck Cancer Trial in Madison (NKTR-214, anti-PD-1 therapy, Palliative Radiation)

Active, not recruiting
  • Head and Neck Cancer
  • Madison, Wisconsin
    University of Wisconsin
May 9, 2022